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TubulinAtaxin-3 (ATXN3) is a widely expressed protein that binds to ubiquitylated proteins, has deubiquitylating
activity in vitro and is thought to modulate substrate degradation through the ubiquitin–proteasome
pathway. Expansion of a polyglutamine tract in ATXN3 causes Machado–Joseph disease, a late-onset
neurodegenerative disorder characterized by ubiquitin-positive aggregate formation and speciﬁc neuronal
death. Although ATXN3 has been involved in transcriptional repression and in the ubiquitin–proteasome
pathway, its biological function is still unknown.
In this work, we show that depletion of ATXN3 using small-interference RNA (siRNA) causes a prominent
phenotype in both human and mouse cell lines. A mild increase in ubiquitylation occurs and cells exhibit
ubiquitin-positive foci, which is consistent with ATXN3 putative function as a deubiquitylating enzyme. In
addition, siATXN3-silenced cells exhibit marked morphological changes such as rounder shape and loss of
adhesion protrusions. At a structural level, the microtubule, microﬁlament and intermediate ﬁlament
networks are severely compromised and disorganized. This cytoskeletal phenotype is reversible and
dependent on ATXN3 levels. Cell–extracellular matrix connection is also affected in ATXN3-depleted cells as
talin expression is reduced in the focal adhesions and lower levels of α-1 integrin subunit are expressed at
their surface. Although the cytoskeletal and adhesion problems do not originate any major change in the cell
cycle of siATXN3-depleted cells, cell death is increased in siATXN3 cultures compared to controls.
In summary, in this work we show that the absence of ATXN3 leads to an overt cytoskeletal/adhesion defect
raising the possibility that this protein may play a role in the cytoskeleton.arch Institute (ICVS), School of
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Ataxin-3 (ATXN3) is the protein involved in Machado–Joseph
Disease (MJD), also known as Spinocerebellar Ataxia Type 3 (SCA3), a
late onset neurodegenerative disorder that belongs to the group of
polyglutamine (polyQ) diseases [1].
ATXN3 possesses a josephin domain (JD) and, depending on the
isoform, two or three ubiquitin interacting motifs (UIMs). ATXN3 has
been involved in the ubiquitin–proteasome pathway (UPP) consid-
ering that (i) it interacts with ubiquitin, polyubiquitin chains,
ubiquitin-like protein Nedd8 and with ubiquitylated proteins [2–5];
(ii) it has deubiquitylating (DUB) activity in vitro mediated by the JD
domain being able to bind and cleave K48 polyubiquitin chains [2,3,6]which are a common recognition motif for proteasomal degradation;
iii) it interacts with subunits of the proteasome [2,7] and iv) with
VCP/p97, known to be involved in the shuttling of substrates for
proteasomal degradation [8,9].
Besides cleaving K48 polyubiquitin chains, ATXN3 also has DUB
activity against K63 chains and mixed linkage chains [10], which
suggests that ATXN3 can be involved in other cellular processes
dependent on K63 linkage such as DNA repair, transcriptional
regulation, endocytosis and activation of protein kinases [11]. In
addition to its role as a DUB, ATXN3 was proposed to repress
transcription by directly binding to chromatin, inhibiting histone
acetylation and by recruiting repressor complexes [12,13].
The cytoskeleton is a heterogeneous network of ﬁlamentous
structures, composed of microﬁlaments, intermediate ﬁlaments, and
microtubules. Neurons are particularly dependent on the cytoskeleton
to deliver the proteins synthesized in the cell body to the axons and
nerve terminals. Therefore, dysfunction of cytoskeletal components
has been proposed as a feature of several neurodegenerative diseases
including Alzheimer´s disease (AD), tauopathies and polyQ disorders
[14,15]. For example, AD is characterized by the formation of insoluble
neuroﬁbrillary tangles (NFT) that contain tau protein, a microtubule
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vesicular trafﬁcking, endo- and exocytosis and axonal polarity. Tau in
NFT is typically hyperphosphorylated and, in this state, tubulin
assembly is impaired [16]. Huntingtin (htt), a polyQ protein involved
in Huntington's disease, co-fractionates with microtubules in vitro,
interacts with β-tubulin and associates with the HAP1 protein, a
partner of dynactin p150Glued, a component of the cytoplasmic
dynein motor responsible for microtubule-dependent retrograde
transport [17,18].
When the cellular chaperones and UPP are both compromised or
overwhelmed, misfolded proteins are transported to form aggre-
somes, which are located in the perinuclear area near the microtu-
bule-organizing center [19]. Microtubules are involved in aggresome
formation as well as the motor proteins dynein and dynactin and the
microtubule-associated protein histone deacetylase 6 (HDAC6)
[20,21]. Interestingly, it has been described that ATXN3 interacts
with dynein and HDAC6, its DUB activity and the ubiquitin-binding
properties of its UIMs being required for aggresome formation [8,22],
although the exact role of ATXN3 in this mechanism remains unclear.
Our previous ﬁndings showing that mouse ATXN3 is highly
expressed in all types of muscle, in ciliated cells and in the ﬂagellum
of spermatozoids [23], and that several transcripts related to
structure/motility were altered in the Caenorhabditis elegans atx-3
knockout animals [24], suggested a possible link between ATXN3 and
the cytoskeleton. In fact, recent data has shown that tubulin interacts
with ATXN3, although the functional relevance of this interaction was
not clariﬁed [8,25].
In this study we used RNA interference-mediated ATXN3 knock-
down to study the cellular role of this protein; we show that lack of
ATXN3 leads to a marked cellular phenotype in both human and
mouse cell lines. Besides accumulating ubiquitylated material in small
foci in the cytoplasm, the ATXN-3-depleted cells are rounder, display
less projections and present evident cytoskeletal disorganization, loss
of cell adhesion and increased cell death.
2. Materials and methods
2.1. RNA interference
Gene regions of human ATXN3 gene (nucleotides 113–826 from
the start codon; NM_004993) and mouse mATXN3 gene (the ﬁrst 646
nucleotides from the start codon; NM_029705), predicted to contain
efﬁcient siRNA target sequences (BLOCKiT RNAi design tool, Invitro-
gen) were ampliﬁed with primers RNAi_hATXN3F+RNAi_hATXN3R
and mmMJD106+mmMJD10, respectively, using standard proce-
dures (Sup. Table 1). The PCR products were then transcribed using
the BLOCK-iT TOPO Transcription Kit (Invitrogen). Diced siRNA pools
were generated from dsRNA using the BLOCK-iT™ Dicer RNAi
Transfection Kit accordingly to manufacturer's instructions (Invitro-
gen). Control siRNA was synthesized using the same protocol. The
primers used for the ampliﬁcation of UBXD8 (control RNAi) were
RNAi_UBXD8F and RNAi_UBXD8R (Sup. Table 1). This gene was used
as a control as it is also involved in the UPP.
2.2. Cell culture and transfection
HeLa cells were purchased from ATCC and grown in Dulbecco's
modiﬁed Eagle's medium (DMEM) (Invitrogen) supplemented with
100 U/ml penicillin/G-streptomycin (P/S), 10% heat inactivated fetal
bovine serum (FBS) and Glutamax. Mouse 3T3-Swiss albino ﬁbro-
blasts were obtained from ATCC (clone CCL-92) and cultured in
DMEM, 10% calf bovine serum (CBS), and 1% P/S. Mouse C2C12
myoblasts were cultured in DMEM/Glutamax, 20% FBS and 1% P/S. All
cell cultures were grown at 37 °C in a 5% CO2 humidiﬁed chamber.
For the RNAi experiments, 1×105 cells were plated in DMEM
medium with 5% FBS/CBS and without antibiotics, on 6-well plates.Approximately 1–2 h later, cells were transfected with 250 ng of
siRNA–lipofectamine complexes prepared in Opti-MEM I medium
(Invitrogen), according to manufacturer's instructions. Transfections
with control siRNA (UBXD8) or with lipofectamine only (mock) were
used as experimental controls.
For the overexpression experiments, 2 μg of pEGFP or pEGFP-
ATXN3_28Q (kindly provided by Dr. H. Paulson) were used for each 6-
well plate. Plasmid–lipofectamine complexes were transfected into
HeLa cells and analyzed 48 h later.
For immunoﬂuorescence procedure, cells were plated on 6-well
plates containing poly-L-lysine coated glass coverslips.
2.3. Immunoﬂuorescence
Depending on the antibodies, cells were ﬁxed for 12 minutes
(min) in freshly prepared 2% paraformaldehyde or ﬁxed for 2 min in
methanol/2 mM EGTA at −20 °C. Cells were then permeabilized
with 0.5% Triton X-100 in PBS for 5 min or with 0.2% Triton X-100 in
TBS for 7 min, respectively. Next, cells were blocked with 10% FBS for
30 min and then incubated with primary antibodies against ATXN3
(rabbit serum kindly provided by Dr. H. L. Paulson, 1:5000 dilution),
anti-α-tubulin (1:100, DSHB, University of Iowa), anti-acetylated α-
tubulin (1:2000, Sigma), anti-vimentin (1:1000, DSHB), anti-
ubiquitin FK2 (1:5000, Biomol), anti-talin (1:200, SantaCruz Bio-
technology). Alexa Fluor 488 and 568 conjugated secondary
antibodies were used at 1:1500 (Molecular Probes). DNA was
stained with DAPI (Sigma).
2.4. Microscopy analysis
Images were acquired as Z-stacks with 0.2–0.3 μm spacing using
an Olympus FluoView FV1000 confocal microscope. Maximal inten-
sity projections of the entire Z-stack are shown.
2.5. Real-time quantitative PCR (qPCR)
One microgram of total RNA puriﬁed from cells was reverse
transcribed using the SuperScript kit (Invitrogen). The qPCR reaction
was performed using the QuantiTec SYBR Green kit (Qiagen) and the
primers described below in a LightCycler device (Roche). Primers used
to amplify hATXN3, UBXD8 and HPRT were: MJD119F+MJD360R,
UBXD8F+UBXD8R and HPRTF+HPRTR (Sup. Table 1). ATXN3 expres-
sion was normalized to HPRT levels within the sample. The normalized
values of siATXN3 were then compared to controls using the ΔΔCt
method [26]. Results are presented as fold change differences of
siATNX3 relative to controls.
2.6. Immunoblotting
For cellular extracts, 40 μg of total protein isolated in NP-40 lysis
buffer (150 mM NaCl, 50 mM Tris–HCl pH 7.6, 0.5% NP-40, 1 mM
PMSF, Complete protease inhibitors (Roche)) were resolved in 10%
SDS-Page gels and then transferred to a nitrocellulose membrane. The
primary antibodies were incubated overnight at 4 °C: anti-MJD1.1
1:2000 [5], anti-α-tubulin (1:100, DSHB), anti-actin (1:2000, DSHB),
anti-acetylated tubulin (1:2000, Sigma), anti-vimentin (1:500, DSHB),
anti-talin (1:200, SantaCruz). After incubation with the secondary
antibodies, membranes were incubated with the SuperSignal Chemi-
luminescence Substrate (Pierce). Films were then analyzed using
ImageJ software.
2.7. α-integrin colorimetric array
Cells were grown and transfected as described above. To perform
the array, ~2×106 cells/ml of each biological replicate were detached
with PBS/3 mM EDTA with the help of a cell scrapper. After 3 washes
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resuspended in assay buffer (provided with the kit); 100 μl of this
suspension was plated into each well of the α- integrin-mediated cell
adhesion array (ECM530, Chemicon) and incubated for 2 h at 37 °C in
a 5% CO2 humidiﬁer chamber. Unbound cells were washed and after
adding cell stain solution and extraction buffer as recommended by
the protocol; absorbance was determined at 540 nm.
2.8. Cell cycle analysis
Cells transfected with control siRNA or siATXN3 were immunos-
tained for phospho-H3 (Sigma) and α-tubulin in order to distinguish
speciﬁc mitotic stages.
For ﬂow cytometry analysis, 1×106 cells were trypsinized,
collected in a 15 ml tube and washed several times with PBS. Cells
were ﬁxed using ice-cold 70% ethanol for 1 h in ice. Cells were washed
with PBS to remove ethanol and then stained with propidium iodide
solution (1 mg/ml propidium iodide, 800 μg/ml RNase in PBS) for 1 h
at room temperature. Samples were washed with PBS and run into an
EPICS XL-MCL ﬂow cytometer (Beckman-Coulter Corporation) as
described before [27]. A minimum of 30,000 cells per sample were
acquired and an acquisition protocol was deﬁned to measure forward
scatter and red ﬂuorescence on a linear scale. Data were analyzed
using the Windows Multiple Document Interface for Flow Cytometry
2.8 (WinMDI 2.8). Four independent replicates were used for
statistical analysis.
2.9. TUNEL assay
For the TUNEL assay, siATXN3 and control siRNA transfected cells
were ﬁxed, permeabilized and stained as advised by themanufacturer
(In Situ Cell Death Detection Kit, POD, Roche). Cells were observed
under amicroscope and random ﬁelds were captured. TUNEL-positive
cells were counted in each ﬁeld and total number of cells was
determined by DAPI positive staining.
2.10. MTS assay
Cells were plated onto 48-well plates and transfected with control
siRNA or siATXN3. MTS reagent (CellTiter 96 Aqueous One Solution
Assay, Promega) was added to each well according to manufacturer's
instructions. After 4 h incubation, absorbance at 490 nm was read
using a BioRad plate reader (BioRad).
2.11. Statistical analysis
For immunoblottings, the mean density and area of each band was
measured using at least three independent experiments in ImageJ
software. Comparison between control siRNA and siATXN3 groups
was done using t-test in the SPSS version 16 software. For Real-Time
PCR data, the same approach was used and results were presented
using the ΔΔ Ct method.
3. Results
3.1. ATXN3 depletion leads to the formation of cellular ubiquitylated foci
and morphological changes
In order to study the cellular role of ATXN3, we performed RNAi-
mediated gene silencing with a pool of siRNAs speciﬁc against the
human and mouse ATXN3 mRNAs. Transfection of siRNAs against
ATXN3 into HeLa and C2C12 cells resulted in a signiﬁcant reduction of
both mRNA and protein levels (Fig. 1A, B, Sup. Fig. 1). The highest
depletion levels of ATXN3 in HeLa and C2C12 cells occurred at 72 h
and 48 h post-transfection, respectively, and the protein levels started
to be restored after that period. Even though we have obtainedefﬁcient depletion of ATXN3 as determined by western blot using
MJD1-1 antibody [5], the immunoﬂuorescence signal for ATXN3 in the
silenced cells was still visible, although lower than controls, especially
in the nucleus (Fig. 1C, D). This is due to the fact that different
antibodies were used for immunoﬂuorescence and wb, since our
antibody works poorly in immunoﬂuorescence and the other
recognized several additional bands in the wb. Therefore, the residual
immunostaining in the immunoﬂuorescence can correspond either to
a different ATXN3 isoform or to unspeciﬁc proteins.
To further conﬁrm the effectiveness of the siRNA, and since
ATXN3 has DUB enzymatic activity, we checked ubiquitin immuno-
reactivity in siATXN3 transfected cells. As shown in Fig. 1C, the
appearance of ubiquitylated foci was more frequently observed in
siATXN3 than in control cells, although not all the siATXN3 cells
displayed these foci. Incubation with the proteasomal inhibitor
MG132 for 1 h further enhanced the formation of these foci in the
siATXN3-treated cells (Fig. 1D). Interestingly, we observed that
siATXN3 cells displayed an odd morphology when compared to
control RNAi-transfected cells (Fig. 1C, D). In contrast with the
stretched elliptical shape of controls, the shape of siATXN3-
transfected cells was rounder with extensive loss of adhesion into
the coverslip surface. Similar results were obtained for mouse C2C12
cells with reduced levels of ATX3 (data not shown).
3.2. ATXN3-depleted cells exhibit cytoskeletal defects
To test if the altered cellular morphology could be a consequence
of cytoskeletal defects, we performed immunoﬂuorescence analysis
for the main components of the cytoskeleton: microtubules (α-
tubulin), microﬁlaments (actin) and intermediate ﬁlaments (vimen-
tin) in siATXN3-transfected cells.
As depicted in Fig. 2A, staining for α-tubulin revealed that the
microtubule network was severely affected in siATXN3 cells in terms of
the spatial array of the ﬁlaments: microtubules were randomly
distributed in these cells in comparison to the parallel regular
distribution observed in control cells. Microtubule nucleation from
the MTOC/centrosome did not seem to be compromised in siATXN3
cells, and actually, therewas an accumulation of ﬁlaments near this area
in comparison with control cells (Fig. 2A). Considering that α-tubulin
acetylation enhances microtubule stability [28] and that ATXN3
interacts with HDAC6, the protein that deacetylates α-tubulin [29],
we thought it would be important to verify the levels and distribution of
acetylatedα-tubulin in siATXN3-transfected cells. Immunoﬂuorescence
assays revealed no apparent alteration in the levels of acetylated α-
tubulin, besides the previously observed loss of parallel spreading of
microtubules across the longest cell axis, suggesting that the microtu-
bule stability is not compromised (Sup. Fig. 2).
As anticipated, staining of ﬁlamentous actin polymers with
phalloidin in control cells showed the presence of parallel stress ﬁbers
and less prominent cortical actin, whereas siATXN3 cells displayed
unparallel stress ﬁbers with no signiﬁcant differences in cortical actin
(Fig. 2B). Analogous results were observed inmouse siATX3 transfected
cells (Sup. Fig. 3).
The intermediate ﬁlaments were also irregularly distributed in
ATXN3 silenced cells (Fig. 2C), exhibiting random spreading instead of
the parallel scattering in control cells.
Although there was an overall disorganization of the cytoskeleton
components in terms of spatial arrangement, their polymerization
seemed to be unaffected (Fig 2).
The protein levels of α-tubulin, acetylated α-tubulin, actin and
vimentin were similar in siATXN3 and control HeLa cells, as
ascertained by western blot (Fig. 2D). Even though the levels of
intact vimentin remained constant, we observed extra bands of lower
molecular weight recognized by the antibody in the ATXN3-depleted
cells, which might correspond to cleavage products arising from
vimentin cleavage by caspases [30].
Fig. 1. ATXN3 depletion leads to ubiquitin-positive foci formation. Delivery of a pool of siRNAs against human ATXN3 lead to a signiﬁcant reduction of its mRNA (A) and protein (B)
levels in HeLa cells. (A) Quantitative RT-PCR results showing that ATXN3 levels were reduced during timecourse of RNAi reaching the maximum silencing at 72 h post-transfection.
Shown is the graph of % of ATXN3 silencing in siATXN3-cells when compared to control RNAi cells. (B) Western blot showing that ATXN3 protein levels were also reduced at 72 h
post-transfection and started to return to normal after 72 h, reaching normal levels at 120 h. α-tubulin was used as a loading control. (C) siATXN3 transfection leads to a slight
increase in ubiquitin staining and the appearance of ubiquitylated foci in HeLa cells. This phenotype was further enhanced by administration of the proteasome inhibitor MG132. The
siATXN3 cells were rounder when compared to the control cells. Scale bar: 20 μm. Rabbit anti-ATXN3 kindly provided by Dr. H. Paulson and stained with secondary antibody Alexa
Fluor 468. Mouse anti-ubiquitin FK2 (Biomol), secondary antibody Alexa Fluor 568.
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Fig. 2. ATXN3 depletion affects the cytoskeleton networks in HeLa cells. (A) Microtubules were disorganized and not parallel as in control cells. Microtubule nucleation from the
MTOC/centrosome did not seem to be compromised in siATXN3 HeLa cells, instead there was an accumulation of ﬁlaments near theMTOC in comparison with control cells (arrows).
(B) Actin ﬁlaments (stained with phalloidin) were unparallel in siATXN3 cells. (C) Vimentin exhibited random spreading when ATXN3 was depleted. (D) Western blot analysis of
these cytoskeletal components shows that their levels were not affected in siATXN3 cells. Vimentin blot presented lower molecular weight bands (*), which can be putative
proteolytic fragments, although the level of intact vimentin remained unchanged. Scale bar: 20 μm. Rabbit anti-ATXN3 kindly provided by Dr. H. Paulson and stained with secondary
antibody Alexa Fluor 468. Mouse anti-tubulin and anti-vimentin from DSHB, secondary antibody Alexa Fluor 568. Phalloidin red from Molecular Probes.
Fig. 3. The cytoskeletal phenotype observed in siATXN3 cells is dependent on ATXN3 levels. At 72 h post-transfection (lowest levels of ataxin-3), the phenotype of HeLa siATXN3-
treated cells was evident: cells were rounder and the microtubule network was disorganized. At 96 h post-transfection, a timepoint when ataxin-3 levels were almost normal, cells
still displayed a cytoskeletal-phenotype but many cells appeared as control cells (arrow). At 120 h post-transfection, when the levels of ATXN3 were normal, the cells no longer
presented detectable microtubule disorganization, although a few cells were still rounder than controls. Immunoﬂuorescence against a-tubulin using secondary antibody Alexa Fluor
568. Scale bar:20 μm.
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In order to see if the RNAi-induced phenotype could be reverted
once ATXN3 levels returned to normal, we examined cells 72, 96 and
120 h post-transfection with siATXN3, 120 h being the time point
when ATXN3 protein was at normal levels. We found that the cellular
morphology and microtubule organization was restored once ATXN3
protein levels returned to normal (Fig. 3). Therefore, we can conclude
that the phenotype observed is reversible and dependent on ATXN3
levels.
3.4. ATXN3 RNAi leads to reduced focal adhesion formation and lower
levels of α-1 integrin subunit at cell surface
Since we clearly observed an abnormal cell morphology in ATXN3
RNAi, we decided to analyze if the siATXN3-depleted cells also
presented adhesion problems. Therefore, we investigated the focal
adhesion points (FAs) through immunostaining for talin, a protein
highly concentrated in regions of cell–substratum contact including
FAs [31]. As shown in Fig. 4A, the talin expression pattern is altered in
siATXN3 cells compared to controls, with signiﬁcant loss of talin
accumulation at FAs. Western blot analysis further conﬁrmed the
reduction of talin expression (Fig. 4B). Overexpression of wild typeFig. 4. ATXN3 RNAi causes a decrease of cell adhesion molecules. Talin expression was decr
blot (B). (C) siATXN3 cells expressed lower levels of α1 integrin subunit at their surface (
Integrin subunit α4 and αVβ3 integrin were not expressed in HeLa cells. Negative control r
biological replicates. Scale bar: 10 μm. Rabbit anti-ATXN3 kindly provided by Dr. H. Paulson
Biotechnology, secondary antibody Alexa Fluor 488.ATXN3 did not lead to any statistical differences in talin expression
levels (Fig. 4B).
Since the connection between FAs and proteins of the extracellular
matrix (ECM) generally involves integrins, and given that talin links
integrins to the actin cytoskeleton [32], we also assessed the levels of
integrin subunits in HeLa ATXN3-depleted cells. Using a colorimetric
array that allows quantiﬁcation of integrin expression at the cell
surface with the use of speciﬁc antibodies, we observed that α1
integrin subunit was signiﬁcantly less expressed in siATXN3 com-
pared to control cells. The other α-integrin subunits did not change
signiﬁcantly, although α3, α5 and αV showed a tendency to be
diminished (Fig. 4C).
3.5. ATXN3 knockdown leads to enhanced cell death in the absence of
mitotic index alterations
Our next aim was to determine which were the consequences of
the cytoskeletal and adhesion problems in ATXN3-depleted cells.
Given that a correct cell division requires an intact microtubule
network and the fact that ATXN3 interacts with α-tubulin and binds
microtubules in human, mouse and C. elegans, with a peculiar
distribution during cell cycle (Sup. Fig. 4), we asked if the cell cycle
progression could be altered in siATXN3-depleted cells. To appraiseeased in ATXN3-depleted cells as ascertained by immunoﬂuorescence (A) and western
t-test, *pb0.05) as measured using the Alpha Integrin-Mediated Cell Adhesion Array.
efers to wells coated with BSA. Error bars refer to standard deviation of 3 independent
and stained with secondary antibody Alexa Fluor 568. Goat anti-talin from SantaCruz
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the number of cells immunopositive for phosphorylated histone H3
over the total number of cells [33] and evaluated the cellular DNA
content using propidium iodide staining and ﬂow cytometry analysis
[34]. As illustrated in Fig. 5A, the mitotic index was similar in control
and siATXN3 knockdown cells (72 h after transfection) and there was
no accumulation of mitotic cells in any speciﬁc stage compared toFig. 5. ATXN3 depletion does not impair themitotic cycle but increases cell death in HeLa cells.
mitotic cell counting using phospho-H3 and α-tubulin immunostaining. (B) The distribution
cytometry (FCM) analysis showed an increase in cell population with abnormal size (forwa
square). An increase in sub-G0/G1 population was observed using propidium iodide staining fo
assay revealed that siATXN3-transfected cells displayed lower metabolic activity than that
conﬁrming that ATXN3 depletion lead to an increase in cell death. A 20×magniﬁcation random
death although to a less extent than siATXN3 cells: Ctr=5.6%, siATNX3=17.4% (F). Error bars r
bar: 20 μm.controls (Fig. 5B). Flow cytometry analysis revealed that siATXN3-
treated cells were cycling similarly to control cells, except that there
was an increase in the sub-G0/G1 population, 13.2% compared to 7.0%
of control cells, consistent with the appearance of a sub-population
with a decreased forward scatter highly correlated with a decrease in
cell size (Fig. 5C). In addition, MTS assays revealed that siATXN3-
depleted cells had reduced metabolic activity (Fig. 5D). Considering(A)Mitotic indexwas similar between control and ATXN3-depleted cells as ascertained by
of siATXN3 cells throughout the mitotic stages was similar to control (CTR). (C) Flow
rd scatter—FSLOG) in siATXN3 cells when compared to control RNAi (population inside
llowed by FCM analysis: Ctr=7±1.1%, siATXN3=13.2±1.0% (t-test, *pb0.05). (D) MTS
of controls from 24 h until 72 h post-transfection (t-test, *pb0.05). (E, F) TUNEL assay
ﬁeld of cells from a representative experiment is shown (E). Controls presented some cell
efer to standard deviation. n≥3 independent biological replicates in all experiments. Scale
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activity are good indicators of cellular death, and the fact that
cytoskeletal defects and adhesion problems are frequently accompa-
nied by an increase in cell death, a mechanism known as anoikis [35],
we used the TUNEL assay to determine the occurrence of DNA
fragmentation-associated cell death. SiATXN3 cells revealed an
increased TUNEL staining (17.4%), indicative of cell death, when
compared to control RNAi (5.6%) (Fig. 5E, F). Thus, data indicate that
ATXN3 knockdown leads to enhanced cell death in the absence of
signiﬁcant mitotic index alterations.
4. Discussion
In polyQ diseases such as MJD, although the polyQ tract itself is
thought to be pathogenic, partial loss of the normal function of the
proteinsmight contribute for the overall pathology and be responsible
for disease-speciﬁc features [1,36,37]. For example, the differential
neuronal vulnerability observed in each polyQ disease may be
explained by the distinct protein context or protein interactions of
the speciﬁc protein involved in that disease. Since the cloning of the
ATXN3 gene in 1994, several efforts have been made to understand its
biochemical function, however, the exact biological role of ATXN3
remains undisclosed.
Here, we report a cellular phenotype due to the absence of ATXN3,
i.e., cells accumulate ubiquitylated foci, display cytoskeletal and
adhesion defects and increased cell death. Analogous to the mouse
ATXN3 knockout model, which also accumulates ubiquitylated
proteins [38], our cellular model of ATXN3 deﬁciency presented
ubiquitin-positive foci, a signal of cellular stress. As expected, the
formation of foci was augmented by the addition of the proteasomal
inhibitor MG132. These foci are not aggresomes, as they are smaller
structures and do not accumulate near the MTOC area. This ﬁnding is
in agreement with other studies which show that ATXN3 depletion
inhibits aggresome formation even in stressful situations [22]. It has
been suggested that ATXN3 DUB activity is required for the formation
of aggresomes, as it may stabilize proteins involved in the trafﬁcking
of misfolded proteins [22]. In addition, we hypothesize that ATXN3
absence leads to cytoskeletal defects, especially in the microtubule
network, which may contribute to the inability to form aggresomes, a
microtubule-dependent process [19,39].
The formation of ubiquitylated foci may suggest that ATXN3 can
act as a DUB in vivo, and imply that the proteins accumulating in these
foci may be putative substrates of ATXN3 DUB activity. While some
studies suggest that the expansion does not affect ATXN3 DUB
activity, at least in vitro [3,10], others suggest that it does [2,8]. For
instance, ERAD substrates have been shown to accumulate in the
presence of expanded ATXN3 [8], suggesting that the mutant protein
may loose some of its activity leading to substrate accumulation.
Hence, it is very appealing to assess what is the protein constitution of
these ubiquitylated foci accumulating in siATXN3 cells, in order to
identify potential ATXN3 substrates, which may eventually be
interesting therapeutic targets.
In this work, in addition to the canonical role proposed for ATXN3
in the UPP, we also found that ATXN3 may have a role in cytoskeleton
organization. Cells with reduced levels of ATXN3 present clear
morphological changes; they are rounder and display less projections.
The polymerization of the microtubule network does not seem to be
affected, but this network is disorganized, with ﬁlaments distributed
in a random rather than parallel fashion, whichwas a quite interesting
ﬁnding if we consider the physical interaction of ATXN3 with α-
tubulin and its ability to bind to microtubules. Dynein is a motor
protein recruited to sites of cell–cell contact, co-localizing with β-
catenin, where it is thought to tether and stabilize the microtubules.
Overexpression of β-catenin and subsequent alteration of dynein
cellular localization severely affects the microtubule array organiza-
tion [40]. Since ATXN3 is known to interact with dynein [22], if dyneinlocalization/function is somehow perturbed in the absence of ATXN3,
this could originate the microtubule disorganization.
The microﬁlament and intermediate ﬁlament networks were also
affected in siATXN3-treated cells. This is not so surprising as it is
known that disruption of one of the cytoskeletal components also
affects the others. For example, several drugs that disrupt or
redistribute microtubules, such as taxol, also affect the intermediate
ﬁlaments [41]. One can hypothesize that the absence of ATXN3 can
ﬁrst lead to the microtubule disorganization, that in turns affects the
organization of other cytoskeletal components.
It is unlikely, however, that the major cytoskeletal proteins are
direct substrates of ATXN3 DUB activity, as their levels remained the
same in siATXN3 cells. Nevertheless, we cannot exclude the possibility
that ATXN3 may be modulating the degradation of other proteins
important for a correct cytoskeletal organization.
In addition to the cytoskeletal defects, we detected a decrease in
the expression of important adhesion-related molecules such as talin
and α1 integrin subunit, indicating that the ECM–cell or cell–cell
interconnection was compromised. Integrins are receptors that are
responsible for binding to speciﬁc ECM proteins and other cells [42].
Concordantly, in a parallel study, we have observed that reduction of
mATXN3 in C2C12 differentiating cells leads to a decrease of α-5 and
α-7 integrin subunits and talin expression among other proteins
important for adhesion, and causes amuscle differentiation delay (MC
Costa et al, unpublished observations). Talin is a ubiquitous protein
highly expressed in focal adhesions (FAs) that links integrins to the
actin network [42]. Although we found a signiﬁcant downregulation
of talin protein in siATXN3-treated cells, overexpression of wild type
ATXN3 did not lead to any differences in talin expression levels when
compared to control cells. Considering the putative role of ATXN3 in
the protein degradation pathway, this ﬁnding may indicate that talin
is not a substrate of ATXN3 and its downregulation may be an indirect
effect of ATXN3 depletion and consequent cytoskeletal abnormalities,
which we did not observe in ATXN3-overexpressing cells (data not
shown). Nevertheless, we can also consider that even if ATXN3 is
being overexpressed, if other proteins important for talin degradation
are present in normal levels, the talin levels may remain the same in
both control and ATXN3-overexpressing cells.
The abnormal cytoskeleton, especially the microtubule disorgani-
zation, can explain the morphological changes of siATXN3 cells, as it is
known that the microtubules can mediate cell shape through
interactions with the actin network in the focal adhesions (FAs)
[43]. Furthermore, some studies that have shown that microtubule
disruption perturbs FA organization, and causes de-regulation of
integrin expression at the cell membrane [44], which we also observe.
However, we cannot exclude the possibility that changes in integrin
levels might be the upstream cause of the cytoskeletal phenotype of
ATXN3-depleted cells.
Given that the cytoskeleton, in particular the microtubules, plays a
fundamental role during mitosis, we analyzed the cell cycle
progression in ATXN3-depleted cells. We did not ﬁnd any differences
in mitotic index and mitotic stage distribution. However, an increase
in sub-G0/G1 population was observed in siATXN3-transfected cells,
indicative of cell death, which was indeed conﬁrmed by the TUNEL
assay. It is unlikely that cell death occurs due to mitotic abnormalities
but rather due to the morphological changes observed. It has been
proven that conditions affecting microtubules lead to cytoskeleton
defects and adhesion problems that are later accompanied by cell
rounding, cell detachment and consequently cell death-anoikis
[44,45], a similar phenotype as the one we observe for siATXN3-
treated cells. Another interesting ﬁnding is the appearance of several
vimentin-immunoreactive low molecular weight bands in siATXN3-
transfected cells. Vimentin is known to be degraded by caspases in
response to apoptotic inducers, probably to facilitate nuclear
condensation and fragmentation. Moreover, vimentin cleavage also
generates an amino-terminal fragment which induces apoptosis, a
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in the case of siATXN3-transfected cells, vimentin is being degraded to
facilitate nuclear fragmentation and apoptosis of cells with abnormal
morphology and/or that its cleavage is inducing apoptosis.
One intriguing aspect of this work is the apparent discrepancy in
the phenotype of the available ATXN3 knockout animals and the
cellular model of ATXN3 deﬁciency we report here. While the C.
elegans ataxin-3 knockout animals are apparently normal [24], the
knockout mouse model only shows a mild increase in ubiquitylation
levels [38]. Cells with reduced ATXN3 levels accumulate ubiquitylated
foci, display cytoskeletal and adhesion problems and increased cell
death. Although the presence of ubiquitylated foci in siATXN3 cells
can parallel the increase in ubiquitin levels in the mouse knockout
model, the cytoskeletal and adhesion deﬁcits were never detected
before. Nevertheless, it has been shown that compensation and
adaptative mechanisms can occur in organisms due to the long-term
absence of a certain protein and some phenotypes only arise in
speciﬁc cell types and not in the whole organism. For example, the
vimentin knockout mice are viable and without any obvious
phenotype [46] while their cultured ﬁbroblasts have abnormal
mechanical properties and are signiﬁcantly more fragile [47]. We
also cannot exclude the fact that very subtle cytoskeletal defects may
exist in these ATXN3 knockout models, which were undetectable
using a gross phenotypical analysis. For example, although apparently
normal in a basal situation, the C. elegans ataxin-3 knockout animals
display a severe motility defect at a stress-threshold growth
condition [48]. Furthermore, recent work from R. Pittman lab has
shown that the ﬁbroblasts from ATXN3 knockout mice are more
sensitive to heat stress than ﬁbroblasts from wild type [49]. Together,
these ﬁndings indicate that additional studies have to be performed in
the available knockout models in order to ascertain how “normal”
they really are.
Our work associates ATXN3 with cytoskeletal organization raising
the possibility that a partial loss of function of this protein can also be
relevant in the disease context by affecting the neuronal cytoskeleton
network.
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